FROM CANDIDATE MOLECULES TO CLINICAL TRIALS: A JOURNEY THROUGH TOXINOLOGY

dc.contributor.authorFerreira, Rui Seabra [UNESP]
dc.contributor.institutionUniversidade Estadual Paulista (Unesp)
dc.date.accessioned2020-12-10T20:03:23Z
dc.date.available2020-12-10T20:03:23Z
dc.date.issued2020-07-01
dc.description.affiliationSao Paulo State Univ UNESP, Ctr Study Venoms & Venomous Anim CEVAP, Botucatu, SP, Brazil
dc.description.affiliationUnespSao Paulo State Univ UNESP, Ctr Study Venoms & Venomous Anim CEVAP, Botucatu, SP, Brazil
dc.format.extentS22-S22
dc.identifier.citationToxicon. Oxford: Pergamon-elsevier Science Ltd, v. 182, p. S22-S22, 2020.
dc.identifier.issn0041-0101
dc.identifier.urihttp://hdl.handle.net/11449/197009
dc.identifier.wosWOS:000543058800048
dc.language.isoeng
dc.publisherElsevier B.V.
dc.relation.ispartofToxicon
dc.sourceWeb of Science
dc.subjectBioproducts
dc.subjectvenoms
dc.subjecttoxins
dc.subjecttrials
dc.subjectresearch and development
dc.titleFROM CANDIDATE MOLECULES TO CLINICAL TRIALS: A JOURNEY THROUGH TOXINOLOGYen
dc.typeResumo
dcterms.licensehttp://www.elsevier.com/about/open-access/open-access-policies/article-posting-policy
dcterms.rightsHolderElsevier B.V.

Arquivos